Publication Name	World Journal of Virology
Manuscript ID	76466
Country	Italy

Received	2022-03-18 14:14
Peer-Review Started	2022-03-18 14:16
To Make the First Decision
Return for Revision	2022-05-12 08:14
Revised	2022-05-20 14:18
Second Decision	2022-07-21 03:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-07-26 22:44
Articles in Press	2022-07-26 22:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-09-16 05:50
Publish the Manuscript Online	2022-09-24 10:56

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment
Manuscript Source	Invited Manuscript
All Author List	Anna Maria Spera
ORCID	Author(s) ORCID Number Anna Maria Spera http://orcid.org/0000-0003-1292-3040
Funding Agency and Grant Number
Corresponding Author	Anna Maria Spera, Doctor, PhD, Doctor, Postdoctoral Fellow, Infectious Disease Unit, Universitary Hospital OORR San Giovanni di Dio e Ruggi d'Aragona, Largo Ippocrate, Salerno 84131, Italy. annamariaspera@hotmail.it
Key Words	Hepatitis B Virus infection; Reactivation; Occult B infection; Chronic B infection; Immunosuppression; Disease-modifying antirheumatic drugs
Core Tip	Hepatitis B Virus (HBV) is a major public health challenge requiring an urgent response. Patients with overt or occult HBV infection can undergo HBV reactivation (HBVr) in course of immunosuppressive treatments, also used in rheumatologic, gastrointestinal, neurological and dermatological settings and to treat Sars severe acute respiratory syndrome coronavirus 2 infection. The aim of the present paper is to investigate the risk of HBVr in those not oncological settings in order to suggest strategies for preventing and treating this occurrence. The occurrence of this challenging event can be reduced screening the population eligible for immunosuppressant to assess the best strategies according to any virological status.
Publish Date	2022-09-24 10:56
Citation	Spera AM. Hepatitis B virus infection reactivation in patients under immunosuppressive therapies: Pathogenesis, screening, prevention and treatment. World J Virol 2022; 11(5): 275-282
URL	https://www.wjgnet.com/2220-3249/full/v11/i5/275.htm
DOI	https://dx.doi.org/10.5501/wjv.v11.i5.275

Full Article (PDF)	WJV-11-275.pdf
Full Article (Word)	WJV-11-275.docx
Manuscript File	76466_Auto_Edited-LM.docx
Answering Reviewers	76466-Answering reviewers.pdf
Audio Core Tip	76466-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	76466-Conflict-of-interest statement.pdf
Copyright License Agreement	76466-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76466-Language certificate.pdf
Peer-review Report	76466-Peer-review(s).pdf
Scientific Misconduct Check	76466-Bing-Liu JH-2.jpg
Scientific Misconduct Check	76466-CrossCheck.jpg
Scientific Editor Work List	76466-Scientific editor work list.pdf